Mirati Therapeutics Inc. buy BiotechBee
Start price
03.01.23
/
60%
€45.00
Target price
31.12.25
€70.00
Performance (%)
-10.09%
End price
05.05.23
€40.46
Summary
This prediction ended on 05.05.23 with a price of €40.46. The price of Mirati Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.09%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -2,20 % | 0,67 % | 0,55 % | 51,11 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % | 34,11 % | 91,99 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % | 53,42 % | 65,85 % |
| iShares S&P 500 | -1,67 % | 2,40 % | 23,22 % | 66,64 % |
According to BiotechBee what are the pros and cons of Mirati Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Buy mit Kursziel 70,0